The Connection Study continues after pre-scheduled Data

On September 30, 2021 Infant Bacterial Therapeutics (IBT) announced that the company had reached a key milestone in the development of IBP-9414, after...

Related Keywords

Serbia ,Hungary ,Stockholm ,Sweden ,United Kingdom ,Israel ,Bulgaria ,Poland ,France ,Spain ,Romania , ,Bacterial Therapeutics ,Nasdaq Stockholm ,Small Cap ,Infant Bacterial Therapeutics ,Abuse Regulation ,Securities Markets ,Stockholm Stock Exchange Ibt B ,Infant Bacterial Therapeutics Ab ,Nbt ,Ec ,Necrotizing Enterocolitis ,Premature Infants ,Preterm ,Orphan Drug ,